Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML

Clinical trial NCT07437170 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07437170
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Pediatric Acute Myeloid Leukemia NUP98 Fusion-positive Acute Myeloid Leukemia

Start date: 2024-01-01
Primary completion: 2027-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.